Suppr超能文献

相似文献

1
A time course of hepcidin response to iron challenge in patients with HFE and TFR2 hemochromatosis.
Haematologica. 2011 Apr;96(4):500-6. doi: 10.3324/haematol.2010.033449. Epub 2010 Dec 20.
2
Blunted hepcidin response to oral iron challenge in HFE-related hemochromatosis.
Blood. 2007 Dec 1;110(12):4096-100. doi: 10.1182/blood-2007-06-096503. Epub 2007 Aug 27.
3
Blunted increase in serum hepcidin as response to oral iron in HFE-hemochromatosis.
Eur J Gastroenterol Hepatol. 2011 Aug;23(8):721-4. doi: 10.1097/MEG.0b013e3283484716.
4
Measurement of urinary hepcidin levels by SELDI-TOF-MS in HFE-hemochromatosis.
Blood Cells Mol Dis. 2008 May-Jun;40(3):347-52. doi: 10.1016/j.bcmd.2007.10.001. Epub 2007 Dec 27.
5
Correlates of hepcidin and NTBI according to HFE status in patients referred to a liver centre.
Acta Haematol. 2015;133(2):155-61. doi: 10.1159/000363490. Epub 2014 Sep 26.
6
Decreased iron burden in overweight C282Y homozygous women: Putative role of increased hepcidin production.
Hepatology. 2013 May;57(5):1784-92. doi: 10.1002/hep.26261. Epub 2013 Apr 4.
8
HFE C282Y homozygotes aged 25-29 years at HEIRS Study initial screening.
Genet Test. 2007 Fall;11(3):269-75. doi: 10.1089/gte.2007.0003.

引用本文的文献

1
HFE-Related Hemochromatosis May Be a Primary Kupffer Cell Disease.
Biomedicines. 2025 Mar 10;13(3):683. doi: 10.3390/biomedicines13030683.
2
Diagnosis and management of hereditary hemochromatosis: lifestyle modification, phlebotomy, and blood donation.
Hematology Am Soc Hematol Educ Program. 2024 Dec 6;2024(1):434-442. doi: 10.1182/hematology.2024000568.
3
Primary Non-HFE Hemochromatosis: A Review.
J Clin Transl Hepatol. 2023 Aug 28;11(4):925-931. doi: 10.14218/JCTH.2022.00373. Epub 2023 Feb 2.
4
Managing the Dual Nature of Iron to Preserve Health.
Int J Mol Sci. 2023 Feb 16;24(4):3995. doi: 10.3390/ijms24043995.
5
NTBI levels in C282Y homozygotes after therapeutic phlebotomy.
EJHaem. 2022 Jul 27;3(3):644-652. doi: 10.1002/jha2.507. eCollection 2022 Aug.
6
Hepcidin and Iron in Health and Disease.
Annu Rev Med. 2023 Jan 27;74:261-277. doi: 10.1146/annurev-med-043021-032816. Epub 2022 Jul 29.
7
The mutual crosstalk between iron and erythropoiesis.
Int J Hematol. 2022 Aug;116(2):182-191. doi: 10.1007/s12185-022-03384-y. Epub 2022 May 27.
8
Clinical Immunoassay for Human Hepcidin Predicts Iron Deficiency in First-Time Blood Donors.
J Appl Lab Med. 2020 Sep 1;5(5):943-953. doi: 10.1093/jalm/jfaa038.
9
10
Hepcidin secretion was not directly proportional to intracellular iron-loading in recombinant-TfR1 HepG2 cells: short communication.
Mol Cell Biochem. 2020 May;468(1-2):121-128. doi: 10.1007/s11010-020-03716-8. Epub 2020 Mar 17.

本文引用的文献

1
Immunochemical and mass-spectrometry-based serum hepcidin assays for iron metabolism disorders.
Clin Chem. 2010 Oct;56(10):1570-9. doi: 10.1373/clinchem.2010.149187. Epub 2010 Aug 25.
2
Evaluation of hepcidin isoforms in hemodialysis patients by a proteomic approach based on SELDI-TOF MS.
J Biomed Biotechnol. 2010;2010:329646. doi: 10.1155/2010/329646. Epub 2010 Apr 15.
6
Hepcidin assay in serum by SELDI-TOF-MS and other approaches.
J Proteomics. 2010 Jan 3;73(3):527-36. doi: 10.1016/j.jprot.2009.08.003. Epub 2009 Aug 13.
7
HFE mutations modulate the effect of iron on serum hepcidin-25 in chronic hemodialysis patients.
Clin J Am Soc Nephrol. 2009 Aug;4(8):1331-7. doi: 10.2215/CJN.01370209. Epub 2009 Jun 18.
8
Hepcidin--a potential novel biomarker for iron status in chronic kidney disease.
Clin J Am Soc Nephrol. 2009 Jun;4(6):1051-6. doi: 10.2215/CJN.05931108. Epub 2009 Apr 30.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验